Form 4 holding
President and CEO, Director
Ernexa Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 118,848
- Estimated value
- Report date
- 31 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount